Telling the Hospital Story: Penn Medicine/Hospital of the University of Pennsylvania
ALS has been very hard to treat. A new drug called Qalsody that is now in experimental trials at Penn Medicine in Philadelphia may make it easier.
Stay updated with breaking news from Todd Legg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ALS has been very hard to treat. A new drug called Qalsody that is now in experimental trials at Penn Medicine in Philadelphia may make it easier.
There’s a promising new drug for people living with amyotrophic lateral sclerosis (ALS). Recently approved by the FDA, Todd Legg participated in an experimental trial for the new drug at Penn Medicine.
On Tuesday, the FDA granted accelerated approval to the drug, tofersen, meaning others with his type of mutation will be able to get the treatment, too — if insurers agree to pay.
Todd Legg started to have trouble breathing in December 2019. Around the same time, he noticed that his hands and arms cramped up when washing dishes at home in Brackney,
Neurologist Toby Ferguson, formerly of Temple University and Penn Medicine, helped develop the Biogen drug, to be sold as Qalsody.